F-Star Therapeutics Inc. buy melinda
Start price
18.09.18
/
50%
€41.24
Target price
05.10.18
€46.90
Performance (%)
14.35%
End price
05.10.18
€47.16
Summary
This prediction ended on 05.10.18 with a price of €47.16. The prediction had a final performance of 14.35%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| F-Star Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread F-Star Therapeutics Inc. diskutieren
SecteurRecherche biotechnologique et médicale
Engages in discovery, development and preparation of bioavailable therapeutics
Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform.
Its pipeline include RIG-I & STING Agonists platforms.
The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 07, 2002 and is headquartered in Hopkinton, MA.
Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform.
Its pipeline include RIG-I & STING Agonists platforms.
The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 07, 2002 and is headquartered in Hopkinton, MA.
Nombre d'employés : 21 personnes.
Stopped prediction by melinda for F-Star Therapeutics Inc.
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.65
07.03.23
07.03.23
€7.00
07.03.24
07.03.24
0.00%
13.02.24
13.02.24
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.52
01.12.19
01.12.19
-
04.11.21
04.11.21
32.74%
05.11.21
05.11.21
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€38.82
02.04.19
02.04.19
€43.30
30.10.19
30.10.19
0.00%
30.10.19
30.10.19
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€53.08
12.12.17
12.12.17
€74.00
12.03.18
12.03.18
19.59%
12.03.18
12.03.18
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.88
12.12.17
12.12.17
€66.75
12.03.18
12.03.18
19.59%
12.03.18
12.03.18
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.66
30.08.17
30.08.17
€66.00
29.09.17
29.09.17
18.89%
29.09.17
29.09.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.11
30.08.17
30.08.17
€59.53
29.09.17
29.09.17
18.89%
29.09.17
29.09.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.00
29.08.17
29.08.17
€66.00
29.08.17
29.08.17
11.61%
29.08.17
29.08.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€46.00
29.08.17
29.08.17
€59.53
29.08.17
29.08.17
11.61%
29.08.17
29.08.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€46.62
22.06.17
22.06.17
€57.01
05.07.17
05.07.17
23.29%
05.07.17
05.07.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.68
22.06.17
22.06.17
€63.20
05.07.17
05.07.17
23.29%
05.07.17
05.07.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.63
08.03.17
08.03.17
€43.30
10.05.17
10.05.17
3.51%
10.05.17
10.05.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.05
10.06.16
10.06.16
€46.90
25.08.16
25.08.16
18.11%
25.08.16
25.08.16